1.
Sudhof, T.: The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature (London). (6)AD.
2.
The synaptic vesicle cycle: a cascade of protein-protein interactions, http://www.nature.com/nature/journal/v375/n6533/pdf/375645a0.pdf.
3.
Chen, K., Neu, A., Howard, A.L., Foldy, C., Echegoyen, J., Hilgenberg, L., Smith, M., Mackie, K., Soltesz, I.: Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures. Journal of Neuroscience. 27, 46–58 (2007). https://doi.org/10.1523/JNEUROSCI.3966-06.2007.
4.
Krisztina, Massa, F., Egertová, M., Eder, M.: The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus.
5.
Nyilas, R., Dudok, B., Urbán, G.M.: Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals.
6.
Solinas, M., Goldberg, S.R., Piomelli, D.: The endocannabinoid system in brain reward processes. British Journal of Pharmacology. 154, 369–383 (2009). https://doi.org/10.1038/bjp.2008.130.
7.
The endocannabinoid system in brain reward processes, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442437/pdf/bjp2008130a.pdf.
8.
Arendt, T.: Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization.
9.
Arendt, T.: Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization.
10.
Dominguez, I.D., Strooper, B.D.: Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer’s disease.
11.
Bezard, E., Brotchie, J.M., Gross, C.E.: Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies : Article : Nature Reviews Neuroscience.
12.
McMurray, C.T.: Huntington’s disease: new hope for therapeutics.
13.
De Keyser, J., Sulter, G., Luiten, P.G.: Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
14.
Zhu, H.L., Luo, W.Q., Wang, H.: Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels.
15.
Fredrik Jarskog, L., Miyamoto, S., Lieberman, J.A.: Schizophrenia: New Pathological Insights and Therapies - Annual Review of Medicine, 58(1):49.
16.
Iritani, S.: Neuropathology of schizophrenia: A mini review. Neuropathology. 27, 604–608 (2007). https://doi.org/10.1111/j.1440-1789.2007.00798.x.
17.
LARUELLE, M., KEGELES, L.S., ABI-DARGHAM, A.: Glutamate, Dopamine, and Schizophrenia. Annals of the New York Academy of Sciences. 1003, 138–158 (2003). https://doi.org/10.1196/annals.1300.063.
18.
Torrey, E.F., Barci, B.M., Webster, M.J., Bartko, J.J., Meador-Woodruff, J.H., Knable, M.B.: Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biological Psychiatry. 57, 252–260 (2005). https://doi.org/10.1016/j.biopsych.2004.10.019.
19.
Löscher, W.: Current status and future directions in the pharmacotherapy of epilepsy.
20.
Mulley, J.C., Scheffer, I.E., Petrou, S., Berkovic, S.F.: Channelopathies as a genetic cause of epilepsy.
21.
Mulley, J.C., Scheffer, I.E., Petrou, S., Berkovic, S.F.: Channelopathies as a genetic cause of epilepsy, http://ovidsp.tx.ovid.com.ezproxy.library.qmul.ac.uk/sp-3.16.0a/ovidweb.cgi?WebLinkFrameset=1&S=OLHFFPBBICDDHECMNCKKKBIBBLDIAA00&returnUrl=ovidweb.cgi%3f%26Full%2bText%3dL%257cjb.search.31.32%257c0%257c00019052-200304000-00009%26S%3dOLHFFPBBICDDHECMNCKKKBIBBLDIAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCIBKBCMIC00%2ffs004%2fovft%2flive%2fgv006%2f00019052%2f00019052-200304000-00009.pdf&filename=Channelopathies+as+a+genetic+cause+of+epilepsy.&pdf_key=FPDDNCIBKBCMIC00&pdf_index=/fs004/ovft/live/gv006/00019052/00019052-200304000-00009&D=ovft.
22.
Maalouf, M., Rho, J.M., Mattson, M.P.: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.
23.
Schmitz, B., Montouris, G., Schäuble, B., Caleo, S.: Assessing the unmet treatment need in partial-onset epilepsy: Looking beyond seizure control. Epilepsia. 51, 2231–2240 (2010). https://doi.org/10.1111/j.1528-1167.2010.02759.x.
24.
Nestler, E.J.: Is there a common molecular pathway for addiction? : Article : Nature Neuroscience.
25.
Dackis, C., O’Brien, C.: Neurobiology of addiction: treatment and public policy ramifications : Article : Nature Neuroscience.
26.
Volkow, N.D., Fowler, J.S., Wang, G.-J.: The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies.